New Developments in the Treatment of Chemotherapy-Induced Neutropenia: Focus on Balugrastim

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s80732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

New Developments in the Treatment of Advanced Squamous Cell Lung Cancer: Focus on Afatinib

OncoTargets and Therapy
OncologyPharmacology
2017English

New Advancements and Developments in Treatment of Renal Cell Carcinoma: Focus on Pazopanib

OncoTargets and Therapy
OncologyPharmacology
2010English

Identification of Targets and New Developments in the Treatment of Multiple Sclerosis &Ndash; Focus on Cladribine

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2010English

Role of Myeloid Growth Factors in Chemotherapy Induced Neutropenia

International Journal of Basic and Clinical Pharmacology
2016English

Chemotherapy-Induced Neutropenia in Pediatric Leukemia: Persian Medicine Perspective

Galen Medical Journal
Medicine
2019English

New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib

OncoTargets and Therapy
OncologyPharmacology
2018English

Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2010English

New Developments in the Management of Overactive Bladder: Focus on Mirabegron and onabotulinumtoxinA

Therapeutics and Clinical Risk Management
2013English

Medical Visits for Chemotherapy and Chemotherapy-Induced Neutropenia: A Survey of the Impact on Patient Time and Activities

BMC Cancer
Cancer ResearchOncologyGenetics
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy